Donald A. Berry
The University of Texas MD Anderson Cancer Center
Donald Arthur Berry is an American statistician and a practitioner and proponent of Bayesian statistics in medical science. He was the chairman of the Department of Biostatistics and Applied Mathematics at the University of Texas M. D. Anderson Cancer Center from 1999-2010, where he played a role in the use of Bayesian methods to develop innovative, adaptive clinical trials. He is best known for the development of statistical theory relating to the design of clinical trials. He is a fellow of th
Read biography ↓Biography, research & contributions
Donald Arthur Berry is an American statistician and a practitioner and proponent of Bayesian statistics in medical science. He was the chairman of the Department of Biostatistics and Applied Mathematics at the University of Texas M. D. Anderson Cancer Center from 1999-2010, where he played a role in the use of Bayesian methods to develop innovative, adaptive clinical trials. He is best known for the development of statistical theory relating to the design of clinical trials. He is a fellow of the American Statistical Association and the Institute of Mathematical Sciences. He founded Berry Consultants, a statistical consulting group, with Scott Berry in 2000.
Affiliation
The University of Texas MD Anderson Cancer Center
Top Publications
- Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer (2005) - 2,519 citations
- Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. (1998) - 2,146 citations
- Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA (2020) - 1,579 citations
- Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 (2003) - 1,577 citations
- Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials (2015) - 1,479 citations
At a glance
- Full name
- Donald A. Berry
- ORCID
- 0000-0002-7657-3871
- OpenAlex ID
- https://openalex.org/A5073571977
Research interests
- Breast Cancer Treatment Studies, Statistical Methods in Clinical Trials, Statistical Methods and Bayesian Inference, Probability and Statistical Research, Breast Lesions and Carcinomas
Research topics
Education
Not yet documented in this profile.
Selected research & further reading
A curated reading list, not a ranking by citation count. References use DOI metadata, matching public scholarly records or authoritative lecture sources.
See the source-linked reading and original works in the research guide above.
Citation & publication trends
Annual counts are not yet available from a verified author record. Explore the research guide above for the work itself; publication and citation totals depend on database coverage.
Source: OpenAlex · Retrieved 2026-10-07. Metrics are database-specific and are not a scientific ranking.
Most-cited linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer ↗2005 · New England Journal of Medicine2,519OpenAlex citations
- 2,146OpenAlex citations
- 1,579OpenAlex citations
- Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 ↗2003 · Journal of Clinical Oncology1,577OpenAlex citations
- 1,479OpenAlex citations
Recent linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer ↗2005 · New England Journal of Medicine
- Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 ↗2003 · Journal of Clinical Oncology
Journals published in
No verified record links added yet.
Related publishers
No verified record links added yet.
Institutions
Current verified institution
No verified record links added yet.
Previous institutions
No verified record links added yet.
Awards & honors
Not yet documented in this profile.
Career timeline
Not yet documented in this profile.
Co-authors
No verified record links added yet.
Education & career institution links
No verified record links added yet.
Claim & manage this profile
Are you this researcher? Sign in, provide identity evidence, and request administrator approval. Editing becomes available only after approval.
Sign in to claim this profileSources & data information
Editorial review: 2026-10-07 · Last data update: 2026-10-07 23:08:02
Unknown values are left blank. Linked publications may be a subset of total works. Identity verification, data retrieval and profile ownership are separate checks.